The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss. Subscribe to read this story ad-free Get unlimited access to ad-free ...

The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, and now he can hear,” said one parent. By Gina Kolata The Food and Drug ...

An experimental gene therapy appears safe and highly effective for restoring hearing to people born with a rare form of deafness, researchers reported Wednesday. The study, the largest and longest to ...

In a blog post shared by the investor on Thursday, Munster predicted that the deliveries would miss analysts' estimates. "We believe next year deliveries will be flat to up 5%," Munster said, ...

In my previous op-ed on Operational Excellence, I argued that no city can thrive without modern systems, clear standards, and a culture of continuous improvement. Today, I want to go deeper — because ...

Essentially all cells in an organism's body have the same genetic blueprint, or genome, but the set of genes that are actively expressed at any given time in a cell determines what type of cell it ...

Alphabet Inc.’s Google DeepMind today introduced AlphaGenome, a new artificial intelligence tool that can comprehensively predict how mutations or variants in human DNA sequences impact gene ...

Panelists discuss how splice modifiers work by enhancing protein production from the SMN2 gene, with risdiplam (Evrysdi) being an oral daily medication and nusinersen (Spinraza) being administered ...

A rare disorder called myotonic dystrophy type 1 (DM1) causes weakness and muscle loss that gets progressively worse. Patients with DM1 are about 14 times more likely to be diagnosed with autism ...

Scientists at the Hospital for Sick Children (SickKids) and the University of Las Vegas Nevada (UNLV) have uncovered a genetic link between autism spectrum disorder (ASD) and a rare genetic condition ...

(RTTNews) - Kraig Biocraft Laboratories, Inc. (KBLB), Tuesday announced that it has successfully launched a next-generation gene-splicing and molecular biology platform. This breakthrough ...